Browsing tag:

congestive heart failure


A recently published study in the American Journal of Kidney Diseases offered a sobering look at the incidence and seriousness of Hyponatremia among hemodialysis patients. Published on April 13, 2013 the aforementioned study focused on patients on hemodialysis and how the condition of Hyponatremia significantly affected their health and mortality risk. Patients who were diagnosed[…]

Read More

Exciting results were revealed in Mid-March of 2013 when the REMINDER trial touted the success of Eplerenone for treating acute ST-Segment Elevation Myocardial Infarction, also known as STEMI. The results from this study were presented at the 62nd Annual Scientific Session of the American College of Cardiology, by Pfizer, who markets Inspra which is the[…]

Read More

Valsartan  is used as a treatment for high blood pressure, as well as congestive heart failure. As part of a class of medications called angiotensin II receptor antagonists, valsartan impedes the action of natural substances in the body that cause a tightening of blood vessels, thus allowing a smoother blood flow to the heart. Also[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service